An observational study in ADHD - Combined Type, ADHD and ADHD Predominantly Inattentive Type, sponsored by Sync-Think, Inc.. Status unknown at 1 site in United States. Open to participants aged 6 Years and older. Per ClinicalTrials.gov, last updated 2020-10-23.
Sponsored by Sync-Think, Inc. · Observational
This study intends to establish a relationship between oculovestibular eye tracking measures, measures of ADHD, and medication prescribed for ADHD.
This study will use a predictive visual tracking paradigm (SyncThink EYE-SYNC eye tracking paradigm) to dynamically capture the participants' attentional state. It will examine the validity of the eye tracking paradigm in identifying the disruption in attentional networks caused by ADHD by examining the association between eye tracking performances and well-established standardized measures of ADHD.
1,514 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 255 are open to participants now.
This study's planned enrollment of 240 is above the median of 127 across 267 observational studies indexed under Attention Deficit Disorder with Hyperactivity.
Browse Attention Deficit Disorder with Hyperactivity studies →Sync-Think, Inc. is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Children and adults seeking diagnosis and/or treatment for attention-related disorder.
Exclusion Criteria:
Clinical diagnosis of a neurological condition including the following: stroke, multiple sclerosis, epilepsy, brain tumor/cancer, dyslexia, nystagmus and/or other major neurological condition.
LAST YEAR: Clinical diagnosis of major depressive disorder; PTSD; clinical diagnosis of substance abuse disorder; major anxiety disorder
Adults seeking treatment for an attention-related disorder
Device: EYE-SYNC
Adults who have been diagnosed with ADHD and prescribed medication treatment for the disorder
Device: EYE-SYNC
Children seeking treatment for an attention-related disorder
Device: EYE-SYNC
Children who have been diagnosed with ADHD and prescribed medication treatment for the disorder
Device: EYE-SYNC
Nystagmograph used to measure eye movement
Eye Tracking and ADHD measure correlation
Zero-order correlations among eye tracking parameters, CAARS ADHD indices, CBRS ADHD indices, and confounding variables
Time frame: through study completion, an average of 1 year
Eye Tracking ADHD Diagnostic ROC
Specific eye tracking parameters will be compared to determine which have the greatest diagnostic utility. Supervised machine learning models will be generated and optimized ROC AUC for both children and adults using eye tracking parameters as input and CAARS indices, CBRS indices, and clinical diagnosis as outcomes
Time frame: through study completion, an average of 1 year
MANCOVA Eye Tracking in ADHD Treatment Population
Repeated measures multivariate analysis of covariance (MANCOVA) will be used to compare eye tracking performance over time in adults and children with ADHD (medicated and unmedicated)
Time frame: through study completion, an average of 1 year
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Attention Deficit Disorder with Hyperactivity→
Sync-Think, Inc.